Mergers & acquisitions
WuXi AppTec, a China CRO/CMO, will acquire ResearchPoint Global, of Texas, a global clinical-stage contract research company, to extend the reach of its own clinical CRO coverage.
TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share.
Two privately-held biotechs have merged to tackle recurrent C. difficile infections.
GIMDx of Carlsbad, California acquired exclusive China OEM and distribution rights to oncology diagnostic products made by IncellDx, a Menlo Park company.
Two factors have increased speculation that Smith & Nephew may be ready for a takeover.
Allergan is a good example of how many mergers and acquisitions over a very short period of time created a large, international company.
WuXi AppTec will acquire a global clinical-stage contract research company, ResearchPoint Global, of Austin, Texas.
Pfizer has increased its stake in Rhythm Pharmaceuticals.
Sachem Head Capital Management is pushing for that company to break up into small entities in order to increase shareholder value.
Amneal and Impax are combining into a new entity that is expected to have the fifth largest generics business in the United States.
PRESS RELEASES